Kevin C. Sagara - Mar 1, 2025 Form 3 Insider Report for SEMPRA (SRE)

Role: Director
Signature: KEVIN C. SAGARA BY: James M. Spira, Associate General Counsel of Sempra and Attorney-In-Fact
Stock symbol: SRE
Transactions as of: Mar 1, 2025
Transactions value $: $0
Form type: 3
Date filed: 3/5/2025, 08:03 PM
Previous filing: Feb 22, 2023
Next filing: Mar 17, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SRE	Common Stock						44.3K	Mar 1, 2025	Direct
holding	SRE	Common Stock						2.36K	Mar 1, 2025	401(k) savings plan (3/1/2025)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	SRE	Phantom Shares							Mar 1, 2025	Common Stock	1.34K		Direct	F1, F2, F3, F4
holding	SRE	Employee Stock Option (right to buy)							Mar 1, 2025	Common Stock	67.1K	$61.90	Direct	F2, F5
holding	SRE	Employee Stock Option (right to buy)							Mar 1, 2025	Common Stock	72.8K	$66.00	Direct	F2, F5
holding	SRE	Employee Stock Option (right to buy)							Mar 1, 2025	Common Stock	42.7K	$76.86	Direct	F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Phantom shares of Sempra Common Stock acquired under Sempra's deferred compensation plan. Total includes additional shares accrued as dividend equivalents since the date of the last report of phantom shares.
F2	Date Exercisable is Immediate.
F3	Expiration Date is Not Applicable.
F4	Conversion of Derivative Security is 1 for 1.
F5	Employee stock options granted while director was previously an officer of Sempra.
F6	Date exercisable is immediate with respect to 28,454 shares; the remaining 14,226 shares subject to the stock option will become exercisable on 01/03/2026.